The Journal of experimental medicine
Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL-10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2g7 congenic mice, which have no Idd alleles other than NOD MHC (H2g7). IL-10 transgenic backcross 1 (BC1) mice with H2g7/g7 haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2g/b haplotype nor nontransgenic BC1 mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL-10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.
Alleles, Animals, B-Lymphocytes, Base Sequence, Crosses, Genetic, DNA Primers, Diabetes Mellitus, Type 1, Female, Genetic Predisposition to Disease, Histocompatibility Antigens Class II, Homozygote, Interleukin-10, Islets of Langerhans, Major Histocompatibility Complex, Male, Mice, Mice, Inbred C57BL, Mice, Inbred NOD, Mice, Inbred Strains, Mice, Transgenic, Molecular Sequence Data, Polymerase Chain Reaction
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.
Lee, Myung-Shik; Mueller, Regula; Wicker, Linda S.; Peterson, Laurence B.; and Sarvetnick, Nora, "IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity." (1996). Journal Articles: Regenerative Medicine. Paper 7.